N

NIDAN LABS AND HEALTH LTD

NIDANNSE
Market snapshot · 2026-08-11 01:49 UTC

13.40

₹-0.05 (-0.37%)

MARKET CAP

STOCK P/E

52W HIGH

₹13.40

52W LOW

₹13.40

BOOK VALUE

EPS

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

1,000

P/B RATIO

PEG RATIO

Sector

Healthcare

Themes

Healthcare
₹14.40₹14.15₹13.90₹13.65₹13.40VolumeAug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for NIDAN.

Coverage check

Price Forecast

Current
₹13.40
High Target
Median Target
Low Target
Price history (1Y)
Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange ()Probability
3M₹8.42 - ₹16.4480%
6M₹6.44 - ₹16.5980%
12M₹4.08 - ₹15.5680%
Realized vol: +52.2% · Drift: -38.4%

Revenue Forecast

₹ Cr
Mar '26Current₹12.0
Sep 2026 ETrend estimate range
High₹16.3Base₹15.1Low₹13.9
Sep '24: ₹11.0 · Mar '25: ₹14.0 · Sep '25: ₹13.0 · Mar '26: ₹12.0 · Sep '26: ₹15.1 · Dec '26: ₹13.9
Sep '24Mar '25Sep '25Mar '26Sep '26 EDec '26 E11.014.013.012.015.113.9
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Mar '26Current₹0.05
Sep 2026 ETrend estimate range
High₹0.81Base₹0.72Low₹0.63
Sep '24: ₹0.79 · Mar '25: ₹0.63 · Sep '25: ₹1.03 · Mar '26: ₹0.05 · Sep '26: ₹0.72 · Dec '26: ₹0.03
Sep '24Mar '25Sep '25Mar '26Sep '26 EDec '26 E0.790.631.030.050.720.03
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Valuation pillar unavailable from supplied valuation. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Supportive
81%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Strong

Fundamentals institutional score is 84 using growth durability 83.6.

Valuation

Unavailable

No valid valuation metrics were supplied.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Strong Trend

Technicals institutional score is 78 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Unavailable

This data source has not been supplied for the decision payload.

Signal Summary

Market intelligence remains Supportive. fundamentals and technical structure provide support.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals StrongTechnical Structure Strong Trend

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical Score78%
Fundamental Score84%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

Sector: Healthcare

Healthcare Peers8 peers
Avg P/E: 24.4x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
68.6x
Premium
+181% vs avg
SUNREST.NS,0P0001RTOB,0
SUNRESTHealthcare
6.4x
Undervalued
-74% vs avg
15.4x
Undervalued
-37% vs avg
7.3x
Undervalued
-70% vs avg
KRMAYURVED
KRMAYURVEDHealthcare
MEDISTEP
MEDISTEPHealthcare
CURIS
CURISHealthcare
WHY THESE PEERS

Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹12 CrMar 2026

Latest net profit

₹0.07 CrMar 2026

Latest EPS

₹0.05Mar 2026

Net margin

18.5%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%5.0%10.0%15.0%20.0%0.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr₹0₹0₹1₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 20260.00 Cr25 Cr50 Cr75 Cr100 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales +13.1414.0910.1811.8212.3510.5313.9913.1212.42
Expenses +9.528.938.548.489.247.9311.5310.5810.12
Operating Profit3.625.161.643.343.112.602.462.542.30
OPM %27.55%36.62%16.11%28.26%25.18%24.69%17.58%19.36%18.52%
Other Income +0.390.333.001.52-5.291.031.221.170.29
Interest0.951.031.190.981.200.881.260.881.07
Depreciation0.871.441.661.281.591.341.070.920.98
Profit before tax2.193.021.792.60-4.971.411.351.910.54
Tax %61.19%23.51%31.28%26.15%3.62%21.99%34.81%24.61%87.04%
Net Profit +0.862.321.221.92-5.151.100.881.430.07
EPS in Rs0.621.670.881.38-3.710.790.631.030.05
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderMar 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +57.04%57.04%57.04%57.04%57.04%
Public +42.96%42.96%42.96%42.96%42.96%
Jun 2026
Promoters +
Public +

Events Timeline

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jul 14, 2026PDFCompany Reports Open

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Jul 09, 2026PDFCompany Reports Open

Copy of Newspaper Publication

May 26, 2026PDFCompany Reports Open

Change in Management

May 25, 2026PDFCompany Reports Open

Outcome of Board Meeting

May 25, 2026PDFCompany Reports Open